Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 342981 - 343000 out of 498429 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Norway | (L01EH01) lapatinib | Tyverb 250 mg | 70 stk, Blisterpakning, Tablett, 250 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | NovartisEuropharmLimited(1) |
| Norway | (L01EH02) neratinib | Nerlynx 40 mg | 180 stk, Beholder av plast, Tablett, filmdrasjert, 40 mg , Beholder av plast | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | PierreFabreMedicament |
| Norway | (L01EH03) tucatinib | Tukysa 150 mg | 84 stk, Blisterpakning, Tablett, filmdrasjert, 150 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms; Neoplasm Metastasis | SeagenNetherlandsB.V |
| Norway | (L01EH03) tucatinib | Tukysa 150 mg | 84 stk, Blisterpakning, Tablett, filmdrasjert, 150 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms; Neoplasm Metastasis | OrifarmAS |
| Norway | (L01EH03) tucatinib | Tukysa 50 mg | 88 stk, Blisterpakning, Tablett, filmdrasjert, 50 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms; Neoplasm Metastasis | SeagenNetherlandsB.V |
| Norway | (L01EH03) tucatinib | Tukysa 50 mg | 88 stk, Blisterpakning, Tablett, filmdrasjert, 50 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms; Neoplasm Metastasis | OrifarmAS |
| Norway | (L01EJ02) fedratinib | Inrebic 100 mg | 120 stk, Flaske, Kapsel, hard, 100 mg , Flaske | Retail price with vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders; Primary Myelofibrosis | Bristol-MyersSquibbPharmaEEIG |
| Norway | (L01EJ02) fedratinib | Inrebic 100 mg | 120 stk, Flaske, Kapsel, hard, 100 mg , Flaske | Retail price with vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders; Primary Myelofibrosis | OrifarmAS |
| Norway | (L01EJ04) momelotinib | Omjjara 100 mg | 30 stk, Flaske, Tablett, filmdrasjert, 100 mg , Flaske | Retail price with vat |
$0-0 |
$0-0 |
n/a | GlaxoSmithKlineTradingServicesLimited |
| Norway | (L01EJ04) momelotinib | Omjjara 150 mg | 30 stk, Flaske, Tablett, filmdrasjert, 150 mg , Flaske | Retail price with vat |
$0-0 |
$0-0 |
n/a | GlaxoSmithKlineTradingServicesLimited |
| Norway | (L01EJ04) momelotinib | Omjjara 200 mg | 30 stk, Flaske, Tablett, filmdrasjert, 200 mg , Flaske | Retail price with vat |
$0-0 |
$0-0 |
n/a | GlaxoSmithKlineTradingServicesLimited |
| Norway | (L01EK01) axitinib | Inlyta 1 mg | 56 stk, Blisterpakning, Tablett, filmdrasjert, 1 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell | PfizerEuropeMAEEIG(1) |
| Norway | (L01EK01) axitinib | Inlyta 3 mg | 56 stk, Blisterpakning, Tablett, filmdrasjert, 3 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell | PfizerEuropeMAEEIG(1) |
| Norway | (L01EK01) axitinib | Inlyta 5 mg | 56 stk, Blisterpakning, Tablett, filmdrasjert, 5 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell | PfizerEuropeMAEEIG(1) |
| Norway | (L01EK01) axitinib | Inlyta 5 mg | 56 stk, Blisterpakning, Tablett, filmdrasjert, 5 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell | OrifarmAS |
| Norway | (L01EK01) axitinib | Inlyta 7 mg | 56 stk, Blisterpakning, Tablett, filmdrasjert, 7 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell | OrifarmAS |
| Norway | (L01EK01) axitinib | Inlyta 7 mg | 56 stk, Blisterpakning, Tablett, filmdrasjert, 7 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell | PfizerEuropeMAEEIG(1) |
| Norway | (L01EL02) acalabrutinib | Calquence 100 mg | 60 stk, Blisterpakning, Kapsel, hard, 100 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell | AstraZenecaAB(2) |
| Norway | (L01EL02) acalabrutinib | Calquence 100 mg | 60 stk, Blisterpakning, Kapsel, hard, 100 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell | OrifarmAS |
| Norway | (L01EL03) zanubrutinib | Brukinsa 80 mg | 120 stk, Flaske, Kapsel, hard, 80 mg , Flaske | Retail price with vat |
$0-0 |
$0-0 |
Waldenstrom Macroglobulinemia | BeiGeneIrelandLimited |
Pages
